drugset / Trial / NCT01670097

Dexamethasone Dyspnea Study

NCT01670097 ↗

Phase 2 Completed 52 enrolled M.D. Anderson Cancer Center
RandomizedCrossoverDouble-blindTreatment

Summary

The goal of this clinical research study is to learn if dexamethasone can help reduce shortness of breath in cancer patients. Researchers also want to learn if it can help to improve lung function and quality of life. In this study, dexamethasone will be compared to a placebo. Dexamethasone is commonly used for treatment of nausea, tiredness, and pain. It may help patients with shortness of breath. A placebo is not a drug. It looks like the study drug but is not designed to treat any disease or illness. It is designed to be compared with a study drug to learn if the study drug has any real effect.

Timeline

Start
2013-01
Primary completion
2020-08
Completion
2021-01-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg Oral